Teva Pharmaceuticals Europe BV has confirmed that the SmPC for COPAXONE® (Glatiramer Acetate (GA) injection) 20mg/mL and 40mg/mL, indicated for the treatment of relapsing forms of multiple sclerosis (RMS) in Europe, has been updated.
Change to COPAXONE(Glatiramer Acetate (GA)) Summary of Product Characteristics (SmPC) in breastfeeding is relevant for the Multiple Sclerosis ("MS") community and provides information for neurologists
Androscoggin County Criminal Court sunjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sunjournal.com Daily Mail and Mail on Sunday newspapers.